Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Trading remains halted pending a fundamental change as described in Policy 8.  The corporate actions announced in this bulletin in no way represent Exchange approval, conditional or otherwise, of the fundamental change transaction.

Canada House Cannabis Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; Canada House Clinics Inc., clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from common to complex medical conditions; IsoCanMed Inc., a Licensed Producer in Louiseville, Quebec, that produces high quality medical grade cannabis; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

 

 

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

Investor Note: In addition to the 213,211,781 common shares that are listed and trading, there are 5,700,000 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 218,911,781.

CannAmerica Brands Corp. is a U.S. marine veteran founded and operated portfolio of cannabis brands with licensing agreements in the United States and Canada.  CannAmerica aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally.  CannAmerica's core strategy is to enhance and monetize the global reach of its existing brands and to pursue additional strategic acquisitions to grow the scope and diversity of its brand portfolio.

Cannibble is a food-tech company that develops and manufactures food and beverage products that are enhanced variously with hemp seeds, hemp protein, and other hemp ingredients, where legal to do so. Cannibble has developed proprietary formulas for food and beverages products that are enhanced with hemp seeds and protein, targeted for the “Better For You” segment. The products are sugar free, dairy free, plant based and non GMO, and marketed under Cannibble’s brand name “The Pelicann”.

Cannibble has developed over 100 product SKUs, of which 40 have been manufactured to date.

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.

Cansortium Inc. is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Miami, Florida.  For more information please visit www.getfluent.com.

Investor Note: In addition to the 226,098,387 Common Shares that are listed and trading, there are 2,723,213 Proportionate Voting Shares, convertible into Common Shares at a ratio of 1:10, that are issued and outstanding but not listed. The total number of issued shares, assuming all are converted into the listed class, would be 253,325,128.

The Exchange has determined that the Issuer has not met the continued listing requirements as set out in CSE Policy 2, Appendix A, section 2.9.

Pursuant to Policy 6 section 2.4, the Issuer may not rely on confidential price protection, nor may the Issuer complete a financing without prior Exchange approval.

In accordance with Policy 3, section 5.1, the .X extension is added to the listed securities of Issuers that the Exchange has deemed to be inactive.

CBD Global Sciences, Inc., is a hemp-based CBD producer and branding investment vehicle which currently owns two brands, branded under the name Aethics™ (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products.  CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online. CBD Global Sciences, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC (www.resinosa.com) and Legacy Distribution Group, (www.legacydistributiongroup.com ), is delivering quality CBD products both in a retail and e-commerce formats nationwide.  The Direct Store Delivery (DSD) provides distribution services for multiple vendors of CBD infused products and non-CBD products throughout the Colorado and Wyoming territories that are currently servicing over 750 C-store and large box retailers with expansion plans to exceed 5,000 stores in the next 12-24 months.  In addition to Legacy Distribution it has added a manufacturing division, Resinosa LLC (www.Resinosa.com ), with its capabilities to provide cGMP manufacturing to the CBD industry with both private label and white label CBD and non-CBD product lines.

.

The business of the Issuer is the development of non-alcoholic beverages and the generation of retail sales.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-12-07-Arcview-Access-Cannabis-Investment-Summit_Website.jpg

Arcview Access Cannabis Investment Summit

Wednesday, December 7, 2022 - 7:00pm to Friday, December 9, 2022 - 1:00pm

Advertisement

Publicité